The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy
Open accessAbstract
Adeno-associated viral (AAV) vectors have demonstrated considerable promise for gene therapy of inherited diseases. However, with a packaging size of <5 kb, applications have been limited to relatively small disease genes. Based on the finding that AAV genomes undergo intermolecular circular concatamerization after transduction in muscle, we have developed a paradigm to increase the size of delivered transgenes with this vector through trans-splicing between two independent vectors coadministered to the same tissue. When two vectors encoding either the 5′ or 3′ portions of the erythropoietin genomic locus were used, functional erythropoietin protein was expressed in muscle subsequent to the formation of intermolecular circular concatamers in a head-to-tail orientation through trans-splicing between these two independent vector genomes. These findings will allow for the application of AAV technologies to a wider variety of diseases for which therapeutic transgenes exceed the packaging limitation of present AAV vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All of these methods require multiple vectors, and the efficiency of some of these methods is inherently limited by the efficiencies of intron processing or homologous recombination.”
From Effect of genome size on AAV vector packaging (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, split vector systems, exploiting head-to-tail concatamerization formation, have been developed to circumvent the small packaging capacity of AAV genomes (13-16, 41, 52).”
From Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry Steps (2005) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“The trans-splicing method to expand the size of ORFs that can be successfully expressed using AAV vectors was originally developed in the laboratory of John Engelhardt 52,53 and has since been utilized in several studies with varying success (e.g., refs. 53-57 ).”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 756
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522
Self-citationSamulski, R. J., Chang, L., & Shenk, T. E. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Animal Model of Adenine-Induced Chronic Renal Failure in Rats
Yokozawa, T., Zheng, P., Oura, H., & Koizumi, F. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183992 · Cited by 356
Biology of Adeno-associated Virus
Berns, K. I., & Giraud, C. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80207-2_1 · Cited by 308
Clark, K. R., Liu, X., McGrath, J. P., & Johnson, P. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950018427 · Cited by 306
Yang, J., Zhou, W., Zhang, Y., Zidon, T. M., Ritchie, T. L., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9468-9477.1999 · Cited by 201
Self-citation
Flagged first, then by citations
1 of the 20 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- N Muzyczka Curr Top Microbiol Immunol 158, 97–129 (1992).
- N Qu, J K Wen, E Li Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 15, 222–224 (1995).
- F Zhang, P Laneuville, R F Gagnon, B Morin, A G Brox Exp Hematol 24, 1469–1474 (1996).
Cited by
Sorted by citations
Items 101–200 of 304
Viral Vectors: A Wide Range of Choices and High Levels of Service
Osten, P., Grinevich, V., & Cetin, A. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_8 · Cited by 54
Kolesnik, V. V., Nurtdinov, R. F., Oloruntimehin, E. S., Karabelsky, A. V., & Malogolovkin, A. S. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1607 · Cited by 53
Yuan, G., Deng, J., Wang, T., Zhao, C., Xu, X.-Z., Wang, P., Voltz, J. W., Edin, M. L., Xiao, X., Chao, L., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0602 · Cited by 50
Lu, H., Chen, L., Wang, J., Huack, B., Sarkar, R., Zhou, S., Xu, R. R., Ding, Q., Wang, X., Wang, H., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.0182 · Cited by 50
Promising and delivering gene therapies for vision loss
Carvalho, L. S., & Vandenberghe, L. H. (2014) · Vision Research · doi:10.1016/j.visres.2014.07.013 · Cited by 51
Recombinant adeno-associated virus vectors for gene therapy
Conlon, T. J., & Flotte, T. R. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1093 · Cited by 49
Regulatable Gene Expression Systems for Gene Therapy
Vilaboa, N. E., & Voellmy, R. W. (2006) · Current Gene Therapy · doi:10.2174/156652306777934829 · Cited by 48
Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear
Akil, O. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107912 · Cited by 47
Wang, Q., Liu, J., Janssen, J. M., Tasca, F., Mei, H., & Gonçalves, M. A. F. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab938 · Cited by 47
Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice
Zhou, Y., Zhang, C., Xiao, W., Herzog, R. W., & Han, R. (2024) · Nature Communications · doi:10.1038/s41467-024-50569-6 · Cited by 48
Size does matter: overcoming the adeno-associated virus packaging limit
Flotte, T. R. (2000) · Respiratory Research · doi:10.1186/rr6 · Cited by 45
Gene Therapy of Inherited Retinal Degenerations: Prospects and Challenges
Trapani, I., Banfi, S., Simonelli, F., Surace, E. M., & Auricchio, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.030 · Cited by 46
Gene therapy: Recombinant adeno-associated virus vectors
Smith-Arica, J. R., & Bartlett, J. S. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0009-x · Cited by 45
AAV-mediated gene transfer for retinal diseases
Allocca, M., Tessitore, A., Cotugno, G., & Auricchio, A. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.12.1279 · Cited by 46
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
Barbon, E., Kawecki, C., Marmier, S., Sakkal, A., Collaud, F., Charles, S., Ronzitti, G., Casari, C., Christophe, O. D., Denis, C. V., et al. (2021) · Gene Therapy · doi:10.1038/s41434-020-00218-6 · Cited by 44
Adeno-associated viral vectors for retinal gene transfer
Surace, E. M., & Auricchio, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00052-1 · Cited by 44
Efficacy of Codelivery of Dual AAV2/5 Vectors in the Murine Retina and Hippocampus
Palfi, A., Chadderton, N., McKee, A. G., Blanco Fernandez, A., Humphries, P., Kenna, P. F., & Farrar, G. J. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.142 · Cited by 42
Translational Research and Therapeutic Perspectives in Dysferlinopathies
Barthélémy, F., Wein, N., Krahn, M., Lévy, N., & Bartoli, M. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00084 · Cited by 42
Hair Cell Transduction Efficiency of Single- and Dual-AAV Serotypes in Adult Murine Cochleae
Omichi, R., Yoshimura, H., Shibata, S. B., Vandenberghe, L. H., & Smith, R. J. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.007 · Cited by 43
Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease
Brommel, C. M., Cooney, A. L., & Sinn, P. L. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.138 · Cited by 43
Yan, Z., Lei-Butters, D. C. M., Zhang, Y., Zak, R., & Engelhardt, J. F. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.128 · Cited by 41
Self-citationLiu, X., Yan, Z., Luo, M., Žák, R., Li, Z., Driskell, R. R., Huang, Y., Tran, N., & Engelhardt, J. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4165-4175.2004 · Cited by 43
Self-citationGene Therapy of ABCA4-Associated DiseasesPreprint
Auricchio, A., Trapani, I., & Allikmets, R. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017301 · Cited by 42
Advances in AAV-mediated gene transfer for the treatment of inherited disorders
Hildinger, M., & Auricchio, A. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201153 · Cited by 40
Overview of Adeno-Associated Viral Vectors
Daly, T. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-650-9:157 · Cited by 39
Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication
Wang, Z., Deng, X., Zou, W., Engelhardt, J. F., Yan, Z., & Qiu, J. (2017) · Journal of Virology · doi:10.1128/jvi.00710-17 · Cited by 41
Self-citationSynthetic Intron Improves Transduction Efficiency of Trans -Splicing Adeno-Associated Viral Vectors
Lai, Y., Yue, Y., Liu, M., & Duan, D. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1036 · Cited by 37
Self-citationDual-AAV delivery of large gene sequences to the inner ear
Reisinger, E. (2020) · Hearing Research · doi:10.1016/j.heares.2019.107857 · Cited by 37
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
Sengillo, J. D., Justus, S., Cabral, T., & Tsang, S. H. (2017) · Genes · doi:10.3390/genes8020053 · Cited by 39
Dual Vectors Expressing Murine Factor VIII Result in Sustained Correction of Hemophilia A Mice
Mah, C. S., Sarkar, R., Zolotukhin, I., Schleissing, M. R., Xiao, X., Kazazian, H. H., & Byrne, B. J. (2003) · Human Gene Therapy · doi:10.1089/104303403321070838 · Cited by 36
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy
Bengtsson, N. E., Tasfaout, H., & Chamberlain, J. S. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.065 · Cited by 36
Present and Future of Adeno Associated Virus Based Gene Therapy Approaches
Ortolano, S., Spuch, C., & Fernández-Balbuena, C. N. (2012) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221412799015245 · Cited by 38
Efficient Production of Dual Recombinant Adeno-Associated Viral Vectors for Factor VIII Delivery
Qizhao, W., Dong, B., Firrman, J., Roberts, S., Moore, A. R., Cao, W., Diao, Y., Kapranov, P., Xu, R., & Xiao, W. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2014.093 · Cited by 35
Pergolizzi, R. G., Ropper, A. E., Dragos, R., Reid, A. C., Nakayama, K., Tan, Y., Ehteshami, J. R., Coleman, S. H., Silver, R. B., Hackett, N. R., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.022 · Cited by 35
Viral vectors for gene delivery to the inner ear
Maguire, C. A., & Corey, D. P. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107927 · Cited by 33
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
French, L. S., Mellough, C., Chen, F. K., & Carvalho, L. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00183 · Cited by 34
Sihn, C., Handyside, B., Liu, S., Zhang, L., Murphy, R., Yates, B., Xie, L. Y., Torres, R., Russell, C. B., O’neill, C. A., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.12.004 · Cited by 33
Adeno-associated Virus and AAV Vectors for Gene Delivery
Carter, B. J., Burstein, H., & Peluso, R. W. (2000) · CRC Press eBooks · doi:10.1201/9781420002126-12 · Cited by 34
Nanotherapy for Duchenne muscular dystrophy
Nance, M. E., Hakim, C. H., Yang, N. N., & Duan, D. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1472 · Cited by 35
Self-citationProspects and problems of gene therapy: an update
Górecki, D. C. (2001) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.6.2.187 · Cited by 32
Kantor, B., O’Donovan, B., & Chiba‐Falek, O. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102635 · Cited by 38
Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia
Markusic, D. M., & Herzog, R. W. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-009 · Cited by 31
Large gene delivery to the retina with AAV vectors: are we there yet?
Trapani, I., Tornabene, P., & Auricchio, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0174-4 · Cited by 30
Boye, S. E., Huang, W.-C., Román, A. J., Sumaroka, A., Boye, S. L., Ryals, R. C., Olivares, M. B., Ruan, Q., Tucker, B. A., Stone, E. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092928 · Cited by 31
White, A. F., Mazur, M., Sorscher, E. J., Zinn, K. R., & Ponnazhagan, S. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.117 · Cited by 31
Promiscuity of Pre-mRNA Spliceosome-Mediated Trans Splicing: A Problem for Gene Therapy?
Kikumori, T., Cote, G. J., & Gagel, R. F. (2001) · Human Gene Therapy · doi:10.1089/104303401750298580 · Cited by 30
Fakhiri, J., & Grimm, D. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.005 · Cited by 29
Dual AAV Vectors for Stargardt Disease
Trapani, I. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_11 · Cited by 30
Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders
Cavalieri, V., Baiamonte, E., & Iacono, M. L. (2018) · Viruses · doi:10.3390/v10060316 · Cited by 29
The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease
Velazquez, L. A. M., & Ballios, B. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111542 · Cited by 27
Delivery Systems for Pulmonary Gene Therapy
Gautam, A. K., Waldrep, C. J., & Densmore, C. L. (2002) · American Journal of Respiratory Medicine · doi:10.1007/bf03257161 · Cited by 26
Dual Vector Expansion of the Recombinant AAV Packaging Capacity
Duan, D., Yue, Y., & Engelhardt, J. F. (2003) · Cardiac Cell and Gene Transfer · doi:10.1385/1-59259-350-x:29 · Cited by 26
Self-citationGreat expectations: virus-mediated gene therapy in neurological disorders
Kariyawasam, D. S. T., Alexander, I. E., Kurian, M. A., & Farrar, M. A. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322327 · Cited by 26
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
Hansen, S., McClements, M. E., Corydon, T. J., & MacLaren, R. E. (2023) · Cells · doi:10.3390/cells12030440 · Cited by 25
AAV- based vector improvements unrelated to capsid protein modification
Shitik, E. M., Shalik, I. K., & Yudkin, D. V. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1106085 · Cited by 28
The dystrophin-associated glycoprotein complex: What parts can you do without?
Sweeney, H. L., & Barton, E. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011510597 · Cited by 25
Gene therapy for pancreatic cancer—current and prospective strategies
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000) · Surgical Oncology · doi:10.1016/s0960-7404(01)00011-1 · Cited by 25
Zhang, H.-G., Wang, Y., Xie, J., Liang, X., Hsu, H.-C., Zhang, X., Douglas, J. T., Curiel, D. T., & Mountz, J. D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301454 · Cited by 25
Lipinski, D. M., Barnard, A. R., Issa, P. C., Singh, M. S., De Silva, S. R., Trabalza, A., Eleftheriadou, I., Ellison, S. M., Mazarakis, N. D., & MacLaren, R. E. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.009 · Cited by 24
PCDH15 dual-AAV gene therapy for deafness and blindness in Usher syndrome type 1F models
Ivanchenko, M. V., Hathaway, D. M., Mulhall, E. M., Booth, K. T. A., Wang, M., Peters, C. W., Klein, A. J., Chen, X., Li, Y., György, B., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177700 · Cited by 24
The new landscape of retinal gene therapy
Ku, C. A., & Pennesi, M. E. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31842 · Cited by 24
Yue, Y., & Duan, D. (2003) · Virology · doi:10.1016/s0042-6822(03)00432-x · Cited by 27
Self-citationGene therapy: light is finally in the tunnel
Cao, H., Molday, R. S., & Hu, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1126-y · Cited by 26
Meng, X., Jia, R., Zhao, X., Zhang, F., Chen, S., Yu, S., Liu, X., Dou, H., Feng, X., Zhang, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48092-9 · Cited by 28
In vivo adenine base editing reverts C282Y and improves iron metabolism in hemochromatosis mice
Rovai, A., Chung, B., Hu, Q., Hook, S., Yuan, Q., Kempf, T., Schmidt, F., Grimm, D., Talbot, S. R., Steinbrück, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32906-9 · Cited by 21
Nicoud, M., Kong, J., Iqball, S., Kan, O., Naylor, S., Gouras, P., Allikmets, R. L., & Binley, K. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1115 · Cited by 22
Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application
Yin, L., He, H., Zhang, H., Shang, Y., Fu, C., Wu, S., & Jin, T. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70447 · Cited by 23
Wu, J., Zhao, W., Li, Y., Zhu, B. L., & Kai-sheng, Y. (2007) · Virology · doi:10.1016/j.virol.2007.07.006 · Cited by 20
Pergolizzi, R. G., & Crystal, R. G. (2004) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.05.008 · Cited by 20
Recombinant Adeno-Associated Virus Gene Therapy for Cystic Fibrosis and α1-Antitrypsin Deficiency
Flotte, T. R. (2002) · CHEST Journal · doi:10.1378/chest.121.3_suppl.98s · Cited by 20
Advances in gene therapy for muscular dystrophies
Abdul-Razak, H. H., Malerba, A., & Dickson, G. (2016) · F1000Research · doi:10.12688/f1000research.8735.1 · Cited by 19
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Yee, T., & Wert, K. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012375 · Cited by 21
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 19
Engineering cell-based therapies to interface robustly with host physiology
Schwarz, K. A., & Leonard, J. N. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.019 · Cited by 20
Wei, X., Zhao, C., Jiang, J., Li, J., Xiao, X., & Wang, D. W. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.372 · Cited by 19
Huang, J., Li, J., Xu, X., & Li, K. (2025) · Biomolecules · doi:10.3390/biom15070940 · Cited by 18
Bişgin, A., Şanlioğlu, A. D., Ekşi, Y. E., Griffith, T. S., & Şanlıoğlu, S. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.052 · Cited by 18
Regulated Gene Expression in Gene Therapy
Zoltick, P., & Wilson, J. M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb11360.x · Cited by 21
Abadie, J., Blouin, V., Guigand, L., Wyers, M., & Chérel, Y. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301773 · Cited by 18
Gardner, K. L., Kearney, J. A., Edwards, J. D., & Rafael‐Fortney, J. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302686 · Cited by 18
Assessment of Therapeutic Potential of a Dual AAV Approach for Duchenne Muscular Dystrophy
Albini, S., Palmieri, L., Dubois, A., Bourg, N., Lostal, W., & Richard, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411421 · Cited by 20
Lung gene therapy—How to capture illumination from the light already present in the tunnel
Xia, E., Munegowda, M. A., Cao, H., & Hu, J. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.001 · Cited by 17
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy
Ingusci, S., Cattaneo, S., Verlengia, G., Zucchini, S., & Simonato, M. (2019) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759718822846 · Cited by 19
Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene
Zhu, F.-X., Liu, Z., Chi, X., & Qu, H. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4011-7 · Cited by 17
Retinal gene therapy: current progress and future prospects
Ku, C. A., & Pennesi, M. E. (2015) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.1035711 · Cited by 16
Maddalena, A., Dell’Aquila, F., Giovannelli, P., Tiberi, P., Wanderlingh, L. G., Montefusco, S., Tornabene, P., Iodice, C., Visconte, F., Carissimo, A., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.220 · Cited by 17
Gene therapy for articular cartilage repair
Trippel, S. B., Cucchiarini, M., Madry, H., Shi, S., & Wang, C. (2007) · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · doi:10.1243/09544119jeim237 · Cited by 16
Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay
McMahon, M., & Maquat, L. E. (2024) · RNA · doi:10.1261/rna.080334.124 · Cited by 16
Riaz, S., Sethna, S., Duncan, T. E., Naeem, M. A., Redmond, T. M., Riazuddin, S. A., Riazuddin, S., Carvalho, L. S., & Ahmed, Z. M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.10.017 · Cited by 15
Engineering Factor Viii for Hemophilia Gene Therapy
Roberts, S. A., Dong, B., & Firrman, J. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-006 · Cited by 15
Dual AAV vectors for efficient delivery of large transgenes
Mittas, D. M., Riedmayr, L. M., Gavrilov, Z., Weber, V. J., Otify, D. Y., Mehlfeld, V., Szalontai, B., Ucambarlic, E., Gandor, C. L. A., Heigl, T., et al. (2025) · Nature Protocols · doi:10.1038/s41596-025-01243-8 · Cited by 18
Maina, N., Li, Z., Li, X., Zhao, W., Han, Z., Bischof, D., Aslanidi, G., Zolotukhin, S., Weigel-Kelley, K. A., Rivers, A. E., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.173 · Cited by 14
Hickey, A. J. (2003) · CRC Press eBooks · doi:10.1201/9780203912898-21 · Cited by 14
Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
McDonald, A. J., & Wijnholds, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052887 · Cited by 16
Hot Topics in Adeno-Associated Virus as a Gene Transfer Vector
Zhao, N., Liu, D., & Liang, C. (2001) · Molecular Biotechnology · doi:10.1385/mb:19:3:229 · Cited by 14
Adeno-Associated Virus-Mediated Gene Transfer for Lung Diseases
Flotte, T. R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.643 · Cited by 13
Gene Therapy for Muscular Dystrophies
Takeda, S., & Miyagoe‐Suzuki, Y. (2001) · BioDrugs · doi:10.2165/00063030-200115100-00001 · Cited by 13
Li, L., Shen, T., Liu, S., Qi, J., & Zhao, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1272786 · Cited by 12
Wu, F., He, W., Xiao, Y., Wu, Q., Zhang, Q., Zhang, T., Xu, L., & Pang, X. (2025) · Advanced Science · doi:10.1002/advs.202408397 · Cited by 12
Castro, M. G., Hurtado‐Lorenzo, A., Umaña, P., Smith-Arica, J. R., Zermansky, A. J., Abordo‐Adesida, E., & Lowenstein, P. R. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32109-x · Cited by 12
Metadata
- Authors
- Yan, Z., Zhang, Y., Duan, D., & Engelhardt, J. F.
- Affiliations
- University of Iowa (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-06-06
- Volume
- 97
- Issue
- 12
- Pages
- 6716-6721
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18714
- OpenAlex
- W2082328650
- Cited by
- 305
- References
- 20
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 5 · 2021: 12 · 2020: 12 · 2019: 14 · 2018: 9 · 2017: 10 · 2016: 7 · 2015: 11 · 2014: 9 · 2013: 14 · 2012: 7
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL058340, R01 HL58340)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 54759, P30DK054759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- adeno-associated virus vectors, trans-splicing, erythropoietin, gene therapy
- MeSH terms
- Dependovirus, Anemia, Animals, Erythropoietin, Genetic Vectors, Kidney Failure, Chronic, Mice, Inbred C57BL, Muscles, Genetic Therapy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
